Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.

Hepatol Int. 2019 Nov;13(6):826-828. doi: 10.1007/s12072-019-09980-1. Epub 2019 Oct 9.

2.

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.

Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Kadir Dokmeci A, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DHG, Kao JH, Ooka Y, Yokosuka O, Sarin SK, Omata M.

Hepatol Int. 2019 Nov;13(6):649-661. doi: 10.1007/s12072-019-09988-7. Epub 2019 Sep 20.

3.

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.

Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6. Erratum in: Hepatol Int. 2019 Nov;13(6):826-828.

4.

Effect of oblique retroreflection from a vibrating mirror on laser Doppler shift.

Agusanto K, Lau GK, Liu T, Zhu C.

Appl Opt. 2019 Mar 20;58(9):2277-2283. doi: 10.1364/AO.58.002277.

PMID:
31044922
5.

Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.

Devarbhavi H, Choudhury AK, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Chawla YK, Dhiman RK, Duseja A, Taneja S, Ning Q, Jia JD, Duan Z, Yu C, Eapen CE, Goel A, Tan SS, Hamid SS, Butt AS, Jafri W, Kim DJ, Hu J, Sood A, Midha V, Shukla A, Ghazinian H, Sahu MK, Treeprasertsuk S, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Kalal C, Abbas Z, Sollano JD, Prasad VGM, Payawal DA, Dokmeci AK, Rao PN, Shrestha A, Lau GK, Yuen MF, Saraswat VA, Shiha G, Yokosuka O, Kedarisetty CK, Jain P, Bhatia P, Sarin SK; APASL ACLF working party.

Am J Gastroenterol. 2019 Jun;114(6):929-937. doi: 10.14309/ajg.0000000000000201.

PMID:
31021832
6.

Modifying Factors for Concussion Incidence and Severity in the 2013-2017 National Hockey League Seasons.

Adams R, Li AY, Dai JB, Haider S, Lau GK, Cheung KP, Post AF, Gometz A, Choudhri TF.

Cureus. 2018 Oct 31;10(10):e3530. doi: 10.7759/cureus.3530.

7.

Effects of Game Characteristics and Player Positions on Concussion Incidence and Severity in Professional Football.

Dai JB, Li AY, Haider SF, Tomaselli R, Gometz A, Sobotka S, Post AF, Adams R, Maniya AY, Lau GK, Kaye-Kauderer HP, Lovell MR, Choudhri TF.

Orthop J Sports Med. 2018 Dec 28;6(12):2325967118815448. doi: 10.1177/2325967118815448. eCollection 2018 Dec.

8.

Evaluation of Concussion Incidence and Modulating Factors in the 2013-2017 Australian Football League.

Adams R, Lau GK, Dai JB, Li AY, Cheung KP, Haider S, Gometz A, Post AF, Choudhri TF.

Cureus. 2018 Oct 18;10(10):e3465. doi: 10.7759/cureus.3465.

9.

APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?

Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DHG, Kao JH, Yokosuka O, Sarin SK, Omata M.

Hepatol Int. 2019 Mar;13(2):103-109. doi: 10.1007/s12072-018-9915-5. Epub 2018 Dec 11.

10.

Optic neuritis as the initial clinical presentation of limbic encephalitis: a case report.

Cheung SSL, Lau GKK, Chan KH, Wong IYH, Lai JSM, Tang WK, Shih KC.

J Med Case Rep. 2018 Dec 3;12(1):357. doi: 10.1186/s13256-018-1893-7.

11.

Transparent Tunable Acoustic Absorber Membrane Using Inkjet-Printed PEDOT:PSS Thin-Film Compliant Electrodes.

Shrestha M, Lu Z, Lau GK.

ACS Appl Mater Interfaces. 2018 Nov 21;10(46):39942-39951. doi: 10.1021/acsami.8b12368. Epub 2018 Nov 8.

PMID:
30365298
12.

Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models.

Choudhury A, Jindal A, Maiwall R, Sharma MK, Sharma BC, Pamecha V, Mahtab M, Rahman S, Chawla YK, Taneja S, Tan SS, Devarbhavi H, Duan Z, Yu C, Ning Q, Jia JD, Amarapurkar D, Eapen CE, Goel A, Hamid SS, Butt AS, Jafri W, Kim DJ, Ghazinian H, Lee GH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Dokmeci AK, Sollano JD, Carpio G, Lau GK, Karim F, Rao PN, Moreau R, Jain P, Bhatia P, Kumar G, Sarin SK; APASL ACLF Working Party.

Hepatol Int. 2017 Sep;11(5):461-471. doi: 10.1007/s12072-017-9816-z. Epub 2017 Aug 30.

PMID:
28856540
13.

Antiplatelet Resumption after Antiplatelet-Related Intracerebral Hemorrhage: A Retrospective Hospital-Based Study.

Teo KC, Lau GKK, Mak RHY, Leung HY, Chang RSK, Tse MY, Lee R, Leung GKK, Ho SL, Cheung RTF, Siu DCW, Chan KH.

World Neurosurg. 2017 Oct;106:85-91. doi: 10.1016/j.wneu.2017.06.015. Epub 2017 Jun 10.

PMID:
28606579
14.

Lifetime Prevalence and Correlates of Schizophrenia-Spectrum, Affective, and Other Non-affective Psychotic Disorders in the Chinese Adult Population.

Chang WC, Wong CSM, Chen EYH, Lam LCW, Chan WC, Ng RMK, Hung SF, Cheung EFC, Sham PC, Chiu HFK, Lam M, Lee EHM, Chiang TP, Chan LK, Lau GKW, Lee ATC, Leung GTY, Leung JSY, Lau JTF, van Os J, Lewis G, Bebbington P.

Schizophr Bull. 2017 Oct 21;43(6):1280-1290. doi: 10.1093/schbul/sbx056.

15.

Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure.

Maiwall R, Sarin SK, Kumar S, Jain P, Kumar G, Bhadoria AS, Moreau R, Kedarisetty CK, Abbas Z, Amarapurkar D, Bhardwaj A, Bihari C, Butt AS, Chan A, Chawla YK, Chowdhury A, Dhiman R, Dokmeci AK, Ghazinyan H, Hamid SS, Kim DJ, Komolmit P, Lau GK, Lee GH, Lesmana LA, Jamwal K, Mamun-Al-Mahtab, Mathur RP, Nayak SL, Ning Q, Pamecha V, Alcantara-Payawal D, Rastogi A, Rahman S, Rela M, Saraswat VA, Shah S, Shiha G, Sharma BC, Sharma MK, Sharma K, Tan SS, Chandel SS, Vashishtha C, Wani ZA, Yuen MF, Yokosuka O, Duseja A, Jafri W, Devarbhavi H, Eapen CE, Goel A, Sood A, Ji J, Duan Z, Chen Y; of the APASL ACLF Research Consortium (AARC) working party.

Liver Int. 2017 Oct;37(10):1497-1507. doi: 10.1111/liv.13443. Epub 2017 Aug 2.

PMID:
28393476
16.

Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.

Choudhury A, Kumar M, Sharma BC, Maiwall R, Pamecha V, Moreau R, Chawla YK, Duseja A, Mahtab M, Rahman S, Hamid SS, Butt AS, Jafri W, Tan SS, Devarbhavi H, Amarapurkar D, Ning Q, Eapen CE, Goel A, Kim DJ, Ghazinyan H, Shiha G, Lee GH, Abbas Z, Payawal DA, Dokmeci AK, Yuen MF, Lesmana LA, Sood A, Chan A, Lau GK, Jia JD, Duan Z, Yu C, Yokosuka O, Jain P, Bhadoria AS, Kumar G, Sarin SK; APASL ACLF working party.

J Gastroenterol Hepatol. 2017 Dec;32(12):1989-1997. doi: 10.1111/jgh.13799.

PMID:
28374414
17.

Tunable window device based on micro-wrinkling of nanometric zinc-oxide thin film on elastomer.

Shrestha M, Lau GK.

Opt Lett. 2016 Oct 1;41(19):4433-4436. doi: 10.1364/OL.41.004433.

PMID:
27749848
18.

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.

Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Al-Mahtab M, McCaughan GW, Wasim J, Crawford DH, Kao JH, Yokosuka O, Lau GK, Sarin SK.

Hepatol Int. 2016 Sep;10(5):681-701. doi: 10.1007/s12072-016-9736-3. Epub 2016 May 26. Review.

19.

APASL consensus statements and recommendation on treatment of hepatitis C.

Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DH, Kao JH, Yokosuka O, Lau GK, Sarin SK.

Hepatol Int. 2016 Sep;10(5):702-26. doi: 10.1007/s12072-016-9717-6. Epub 2016 Apr 29. Review.

20.

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lim SG, Liu CJ, Locarnini S, Al Mahtab M, Mohamed R, Omata M, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH.

Hepatol Int. 2016 Jan;10(1):1-98. doi: 10.1007/s12072-015-9675-4. Epub 2015 Nov 13.

21.

Interferon for Chinese patients with chronic hepatitis B e antigen-positive diseases-the controversy arises again?

Lau GK.

Hepatol Int. 2014 Jul;8(3):301-3. doi: 10.1007/s12072-014-9550-8. Epub 2014 Jul 9. No abstract available.

PMID:
26202632
22.

Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Omata M, Kanda T, Yokosuka O, Crawford D, Al-Mahtab M, Wei L, Ibrahim A, Lau GK, Sharma BC, Hamid SS, Chuang WL, Dokmeci AK.

Hepatol Int. 2015 Oct;9(4):486-507. doi: 10.1007/s12072-015-9630-4. Epub 2015 May 5. Review.

PMID:
25941137
23.

Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.

Zhang XX, Wang LF, Jin L, Li YY, Hao SL, Shi YC, Zeng QL, Li ZW, Zhang Z, Lau GK, Wang FS.

World J Gastroenterol. 2015 Mar 28;21(12):3554-63. doi: 10.3748/wjg.v21.i12.3554.

24.

How do we handle the anti-HBc positive patient? (in highly endemic settings).

Lau GKK.

Clin Liver Dis (Hoboken). 2015 Mar 27;5(2):29-31. doi: 10.1002/cld.399. eCollection 2015 Feb. No abstract available.

25.

Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy.

Ho EY, Yau T, Rousseau F, Heathcote EJ, Lau GK.

Hepatol Int. 2015 Apr;9(2):224-30. doi: 10.1007/s12072-015-9612-6. Epub 2015 Mar 12.

PMID:
25788197
26.

Complete response of acquired FV inhibitor to rituximab.

Ma ES, Liang RH, Chu KM, Lau GK.

Int J Hematol. 2015 Apr;101(4):421-2. doi: 10.1007/s12185-015-1742-z. Epub 2015 Jan 24. No abstract available.

PMID:
25616916
27.

Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B.

Leung NW, Herrmann E, Lau GK, Chan HL, So TM, Zeuzem S, Dong Y, Trylesinski A, Naoumov NV.

Infect Dis Ther. 2014 Dec;3(2):191-202. doi: 10.1007/s40121-014-0039-5. Epub 2014 Sep 17.

28.

Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.

Chan KH, Lee R, Lee JC, Tse AC, Pang SY, Lau GK, Teo KC, Ho PW.

J Neuroimmunol. 2013 Sep 15;262(1-2):100-5. doi: 10.1016/j.jneuroim.2013.06.004. Epub 2013 Jul 6.

PMID:
23838529
29.

Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma.

Fu J, Zhang Z, Zhou L, Qi Z, Xing S, Lv J, Shi J, Fu B, Liu Z, Zhang JY, Jin L, Zhao Y, Lau GK, Zhao J, Wang FS.

Hepatology. 2013 Jul;58(1):139-49. doi: 10.1002/hep.26054. Epub 2013 Feb 15.

PMID:
22961630
30.

Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients.

Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, Chen L, Lv S, Li Y, Yu S, Geng H, Jin L, Lau GK, Wang FS.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:112-20. doi: 10.1111/j.1440-1746.2011.07024.x.

PMID:
22320928
31.

Uncover the immune biomarkers underlying hepatitis B e antigen (HBeAg) seroconversion: a need for more translational study.

Lau GK, Wang FS.

J Hepatol. 2012 Apr;56(4):753-5. doi: 10.1016/j.jhep.2011.12.006. Epub 2012 Jan 8. No abstract available.

32.

Management of chronic hepatitis B e antigen-negative disease: another step forward.

Lau GK, Wang FS.

J Infect Dis. 2012 Jan 1;205(1):7-9. doi: 10.1093/infdis/jir694. Epub 2011 Nov 17. No abstract available.

PMID:
22095767
33.

Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

Desmond CP, Gaudieri S, James IR, Pfafferott K, Chopra A, Lau GK, Audsley J, Day C, Chivers S, Gordon A, Revill PA, Bowden S, Ayres A, Desmond PV, Thompson AJ, Roberts SK, Locarnini SA, Mallal SA, Lewin SR.

J Virol. 2012 Jan;86(2):1181-92. doi: 10.1128/JVI.05308-11. Epub 2011 Nov 9.

34.

Nonalcoholic steatohepatitis treatment.

Luong M, Lau GK.

Gastroenterology. 2011 Sep;141(3):1121-3; discussion 1123. doi: 10.1053/j.gastro.2011.07.012. Epub 2011 Jul 23. No abstract available.

PMID:
21791210
35.

Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.

Li J, Lau GK, Chen L, Dong SS, Lan HY, Huang XR, Li Y, Luk JM, Yuan YF, Guan XY.

PLoS One. 2011;6(7):e21816. doi: 10.1371/journal.pone.0021816. Epub 2011 Jul 7.

36.

Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations.

Sarin SK, Kumar A, Angus PW, Baijal SS, Baik SK, Bayraktar Y, Chawla YK, Choudhuri G, Chung JW, de Franchis R, de Silva HJ, Garg H, Garg PK, Helmy A, Hou MC, Jafri W, Jia JD, Lau GK, Li CZ, Lui HF, Maruyama H, Pandey CM, Puri AS, Rerknimitr R, Sahni P, Saraya A, Sharma BC, Sharma P, Shiha G, Sollano JD, Wu J, Xu RY, Yachha SK, Zhang C; Asian Pacific Association for the Study of the Liver (APASL) Working Party on Portal Hypertension.

Hepatol Int. 2011 Jun;5(2):607-24. doi: 10.1007/s12072-010-9236-9. Epub 2011 Feb 19.

37.

Photochemical properties of CeO2-coated ZnO nanorods.

Lau GK, Zhang TS, Goh GK.

J Nanosci Nanotechnol. 2010 Jul;10(7):4733-7.

PMID:
21128489
38.

Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis.

Cheung CK, Lo CM, Man K, Lau GK.

Liver Transpl. 2010 Nov;16(11):1314-23. doi: 10.1002/lt.22169.

39.
40.

STAT3 implicated in the development of colon cancer: a step closer for targeted therapy?

Lau GK, Ye D.

Gastroenterology. 2010 Jul;139(1):353-5. doi: 10.1053/j.gastro.2010.05.030. No abstract available.

PMID:
20639089
41.

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.

Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV, Locarnini SA.

Hepatology. 2010 Jun;51(6):1933-44. doi: 10.1002/hep.23571.

PMID:
20512987
42.

Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.

Chen L, Ho DW, Lee NP, Sun S, Lam B, Wong KF, Yi X, Lau GK, Ng EW, Poon TC, Lai PB, Cai Z, Peng J, Leng X, Poon RT, Luk JM.

Ann Surg Oncol. 2010 Sep;17(9):2518-25. doi: 10.1245/s10434-010-1038-8. Epub 2010 Mar 31.

43.

Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection.

Liaw YF, Lau GK, Kao JH, Gane E.

Dig Dis Sci. 2010 Oct;55(10):2727-34. doi: 10.1007/s10620-010-1179-4. Epub 2010 Mar 18. Review.

PMID:
20238245
44.

Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion.

Lau GK.

Liver Int. 2010 Apr;30(4):512-20. doi: 10.1111/j.1478-3231.2009.02198.x. Epub 2010 Jan 19. Review.

PMID:
20102511
45.

Novel insights into the association between HLA-DP variants and persistent hepatitis B virus infection: a genome-wide association study.

Lau GK, Ye D.

Gastroenterology. 2010 Jan;138(1):394-6. doi: 10.1053/j.gastro.2009.11.030. Epub 2009 Nov 20. No abstract available.

PMID:
19932209
46.

Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.

Buster EH, Hansen BE, Lau GK, Piratvisuth T, Zeuzem S, Steyerberg EW, Janssen HL.

Gastroenterology. 2009 Dec;137(6):2002-9. doi: 10.1053/j.gastro.2009.08.061. Epub 2009 Sep 6.

PMID:
19737568
47.

Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.

Erhardt A, Göbel T, Ludwig A, Lau GK, Marcellin P, van Bömmel F, Heinzel-Pleines U, Adams O, Häussinger D.

J Med Virol. 2009 Oct;81(10):1716-20. doi: 10.1002/jmv.21588.

PMID:
19697400
48.

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF.

Hepatol Int. 2009 Mar;3(1):269-82. doi: 10.1007/s12072-008-9106-x. Epub 2008 Nov 20.

49.

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.

Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S; Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver.

Hepatol Int. 2008 Sep;2(3):263-83. doi: 10.1007/s12072-008-9080-3. Epub 2008 May 10.

50.

Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats.

Ye X, Feng Y, Tong Y, Ng KM, Tsao S, Lau GK, Sze C, Zhang Y, Tang J, Shen J, Kobayashi S.

J Ethnopharmacol. 2009 Jul 6;124(1):130-6.

PMID:
19536921

Supplemental Content

Support Center